Great Q2 results for iCAD! My first GM, who hired me from clinical research into clinical marketing many years ago, frequently said: “The more successful we are, the fewer patients will be impacted by cancer.” This resonates more than ever as I celebrate my 1-year #anniversary at iCAD, and we continue to push boundaries of early breast cancer detection, striving to Create a World Where Cancer Can't Hide. We are thrilled to report a 21% YoY revenue increase and a continued upward trend across key impact metrics: ?? Closed 60 perpetual, 29 subscription, and 10 cloud deals ?? Launched our cutting-edge #ProFoundAI Cloud solution ?? Formed strategic growth partnerships with Densitas Inc. and CancerIQ ?? Achieved Total ARR of $9.2 million, up 7% ?? Delivered $5.0 million in total revenues ?? Improved Gross Profit Margin to 84% from 81% ?? Reduced GAAP net loss from continuing operations to ($1.7) million, a significant improvement from ($2.3 million) A true testament to the hard work and innovation happening across all departments at iCAD and our partners -?GO TEAM!
Today iCAD announced results for its fiscal second quarter ended June 30, 2024. “The second quarter of 2024 was highlighted by strong revenue growth of 21%, underscoring the success of our strategic direction as we continue to drive consistent performance,” said Dana Brown, President and CEO of iCAD, Inc. “In line with phase 3 of our transformation plan, this quarter we continued to maximize revenue from our sizeable install base, upgrading customers to new versions including the transition to Cloud, and accelerating deployment across large, national accounts. In the second quarter, we closed 60 perpetual, 29 subscription, and 10 cloud deals with both new and established customers. Our efforts to reduce expenses and grow sales are yielding results. “This was our first full quarter offering our ProFound Cloud SaaS platform and the offering is being received better than expected by both existing and new customers. This solution not only empowers customers but should also create a more predictable and robust economic model for the business over time as it grows as a percentage of revenue.” Read more: https://bit.ly/4dlF543
Congrats team iCAD! I wish you all continued success creating a world where cancer can't hide!
Well done! We love watching the success of iCAD
Love this progress and impact Jeremiah R. Bennett!
Congrats JB!
Well done!
Creative | Determined| Loyal
3 个月Congratulations JB! ????